By utilising mutant SOD1 mouse models of ALS, the past 20 years have included assessment of a large and diverse number of treatments targeting excitotoxicity, oxidative stress, inflammation, mitochondrial dysfunction, abnormal protein aggregation and dysregulated metabolism [37]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.